• Scientists Crack the Code of a Cancer-Related Enzyme, Opening Doors to New Treatments

    Cancer remains a global health challenge, two exciting new studies published in the Journal of the American Chemical Society are shedding light on an enzyme called beta-1,3-galactosyltransferase 5 (β3GalT5)... Read More
  • 2025 Summer Internship for Undergraduates – Now Open for Applications!

    Scientific research is an endless journey of exploration and discovery! We sincerely invite passionate and curious minds to challenge themselves, broaden their horizons, and dive into the world of research. Make this summer count - start your journey with the GRC Summer Internship! Read More
  • Dr. Che Alex Ma Received 2024 Outstanding Research Award from National Science and Technology Council

    Dr. Che Alex Ma specializes in structural biology, exploring the important roles of membrane proteins and glycoproteins in infectious diseases and cancers. Notably, his recent major achievements include... Read More
  • 2025 Youth in Health Science Summer Program

    JOIN US IN 2025! Take the next step in your scientific journey and explore exciting frontiers in health science with leading experts and a community of like-minded peers! Apply Now & Be Part of This Transformative Experience! Read More
  • Genomics Research Center 20th Anniversary Celebration

    To commemorate this milestone, GRC held its 20th Anniversary Celebration on December 11, 2024. We sincerely thank former and current GRC members, collaborators, and esteemed guests for joining us in celebrating the growth and achievements of the GRC. Read More
  • The 2024 National Innovation Improvement Award

    Congratulations to Dr. Yun-Ru (Ruby) Chen's team winning the 2024 National Innovation Improvement Award. For more details, please see... Read More
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6

語言

HONORS & APPOINTMENTS

  • Congratulations to Dr. Chien-Te Chou and Yi-Hsueh Lin from Dr. Li-Jung Juan‘s Lab for receiving the Honorable Mention in the
    Read More
  • Congratulations to Ms. Dan-Ni Wu from Dr. Chun-Mei Hu's Lab for being awarded the 2025 AS-TIGP Ph.D. Students' Research Progress Fellowship.
    Read More
  • 2024 GRC Research Award Winners Announcement
    Read More
  • Congratulations to Dr. Tien-Ying Tsai from Dr. Yun-Ru (Ruby) Chen‘s Lab for receiving the Best Poster Prize of Tien Te
    Read More

Research in GRC Series

Research News

  • All
  • PopularScience
  • ResearchNews
load more hold SHIFT key to load all load all

Tsai, Ming-Daw

Distinguished Research Fellow / Institute of Biological Chemistry, Academia Sinica


Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Telephone: +886-2-2789-9363
[ CV ]
[ Webpage ]

 

 

EDUCATION AND POSITIONS HELD:

  • B.S., Chemistry, National Taiwan University, Taipei, 1972
  • Ph.D, Biochemistry & Medicinal Chemistry, Purdue University, 1978
  • Kimberly Professor of Chemistry and Professor of Biochemistry, The Ohio State University (starting 1981 as Assistant Professor)
  • Director, Office of Research Campus Chemical Instrument Center, The Ohio State University, 1993-present
  • Director, Chemistry/Biology Interface Training Program, OSU, 1995?003
  • Director, Comprehensive Cancer Center Proteomics Shared Resource, OSU

HONORS:

  • Alfred P. Sloan Fellow, 1983-1985
  • Camille and Henry Dreyfus Teacher-Scholar, 1985-1990
  • Distinguished Scholar Award, The Ohio State University, 1992
  • Elected Fellow, American Association for the Advancement of Science, 1992
  • Co-chair, Gordon Conference on Enzymes, 1993
  • Board of Consulting Editors, Bioorganic & Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters, 1998-present
  • President, Chinese American Chemical Society, 2003

RESEARCH INTERESTS:

The main research program of Tsai lab focuses on proteins involved in cell cycle progression that are closely related with cancer and virus infection. Our structure and function studies on INK, CDK4, and Chk2 proteins shed great light on the mechanisms underlying some cancer diseases, while our enzymological characterizations of human and viral polymerases empower us to further understand the DNA damage response and repair at DNA level. Development of inhibitors and activators for cell cycle promoter (CDK4) and suppressor (Chk2) proteins, and the establishment of a novel in vitro and in vivo combined method to identify and investigate the binding targets for cancer-related proteins are being employed for the discovery of potential therapeutic approaches.